Last 12mo stats

mentions

voices

$TIL

Instil Bio Inc

Share on X

$TIL

Instil Bio Inc

Past 12mo:12mentions1voices

Share on X

All voices16 mentions past 12mocalls only

Loading price chart…

Frequently asked

Who mentions $TIL most on Surfaced?

@jacobplieth (Jacob Plieth) mentions $TIL most — 16 mentions in the past 12 months.

When was $TIL first mentioned on Surfaced?

The earliest tracked mention of $TIL in the Surfaced archive was on Jul 31, 2025.

How many voices track $TIL?

1 FinTwit voice has mentioned $TIL 12 times in the past 12 months.

What kind of voices mention $TIL most?

$TIL is mentioned most by Biotech voices on Surfaced.

Recent mentions

16 mentions

@jacobpliethJan 14, 2026 · 12:00 PM

Seven days after $TIL pulled the plug, Immuneonco says it's still independently developing its PD-L1 x VEGF trap palverafusp alfa https://t.co/MVeWhOiLrv $SMMT $BNTX

Open on X

@jacobpliethJan 7, 2026 · 9:47 AM

And here's Immuneonco's statement on the $TIL discontinuation. Still says nothing about the reason(s) https://t.co/mX37CLgjz6

Open on X

@jacobpliethJan 6, 2026 · 1:24 PM

How many people had $TIL scrapping the Immuneonco deal, discontinuing PD-1 x VEGF, and going back to TIL therapeutics on their #JPM26 bingo card?

Open on X

@jacobpliethOct 16, 2025 · 1:06 PM

PD-1 x VEGF news: Shanghai Junshi says it's got FDA approval to start a US ph2/3 trial of JS207 head-to-head vs Opdivo in neoadjuvant NSCLC $SMMT $TIL $BNTX https://t.co/77Fpme5Pvo

Open on X

@jacobpliethSep 7, 2025 · 7:23 PM

More doubts for $SMMT as the Harmoni guessing game continues at #WCLC25. Via @ApexOnco -> https://t.co/riemtQP53v $BNTX $TIL $BMY

Open on X

@jacobpliethAug 21, 2025 · 7:45 PM

Plus some other #WCLC25 presentations of note: https://t.co/xavXaIItJu $LEGN $TIL $NVS $BNTX $CADL

Open on X

@jacobpliethAug 13, 2025 · 10:11 AM

So Immuneonco is presenting AXN-2510/ IMM2510 NSCLC data (apparently only for squamous histology) at #WCLC25. $TIL starting its own US study by year end 2025. $SMMT

Open on X

@jacobpliethJul 31, 2025 · 2:02 PM

Did $TIL get a bargain when it bought a PD-L1 x VEGF bispecific from Immuneonco? You decide. Via @ApexOnco -> https://t.co/kwsOLp3y4f $SMMT $BNTX $BMY $PFE $MRK

Open on X

@jacobpliethJul 31, 2025 · 1:13 PM

Looking for X-trial comparisons for the $TIL ImmuneOnco data? $RHHBY Impower-150 is one, and here's another: Akeso ph2 ORRs for ivonescimab + chemo from #ELCC24 $SMMT https://t.co/HRqz3MDiff

Open on X

@jacobpliethJul 31, 2025 · 10:29 AM

Seems most of the $TIL PD-L1 x VEGF responses are unconfirmed at this point... why announce now?? $SMMT $BNTX $PFE https://t.co/MJyOCPEbho

Open on X

@jacobpliethJul 31, 2025 · 10:22 AM

Here's the original release from Immuneonco -> https://t.co/Vtk9xHyRts Note $TIL IMM2510 / AXN-2510 = palverafusp alfa $SMMT

Open on X

@jacobpliethJul 31, 2025 · 10:10 AM

$TIL PD-L1 x VEGF $SMMT https://t.co/SoeDVEiZrs

Open on X

@jacobpliethJun 2, 2025 · 5:48 PM

How $BNTX turned $800m into $1.5bn, via @ApexOnco -> https://t.co/5BVk9OWMYr Who will be next? #ASCO25 $BMY $PFE $SMMT $TIL

Open on X

@jacobpliethJun 2, 2025 · 5:31 PM

Well well well (Immuneonco is the originator of $TIL AXN-2510) #ASCO25 https://t.co/MZdekS9acP

Open on X

@jacobpliethJun 2, 2025 · 5:27 PM

Just out of interest, here's Huabo's sotiburafusp alfa and $TIL SYN-2510/ AXN-2510. Both are PD-L1 x VEGF-trap fusion proteins. I wonder how strong the IP of each one is #ASCO25 https://t.co/E5FJ20B2jm

Open on X

@jacobpliethJun 2, 2025 · 12:05 PM

Also: $TIL got passed over by big pharma for the second time in two weeks?? $BNTX $BMY $SMMT $PFE

Open on X